The incidence of ductal carcinoma in situ (DCIS) of the breast has greatly increased in
countries with breast cancer early detection programs. However, uncertainty remains about …

Abstract Ductal Carcinoma in Situ (DCIS) is a non obligate precursor of invasive breast
cancer. Due mainly to improved screening methods the detection of DCIS has risen over the …

The spread of mammographic screening programmes around the world, including in
developing countries, has substantially contributed to the diagnosis of small non-palpable …

Ductal carcinoma in situ (DCIS) represents a proliferation of malignant epithelial cells within
the ducts and lobules of the breast, without invasion through the basement membrane. It is …

Despite recent improvements in the breast cancer mortality rate, breast cancer remains the
most common cancer and the second leading cause of cancer-related deaths in US women …

Ductal carcinoma in situ (DCIS) of the breast is a potentially invasive neoplasm. Risk factors
include high estrogen states such as use of oral contraceptive (OC) pills, nulliparity …

Most invasive breast cancers arise from ductal carcinoma in-situ (DCIS), a non-obligate
precursor of invasive breast cancer. Given that the natural history of individual DCIS lesions …

Ductal carcinoma in situ (DCIS) of the breast is a heterogeneous group of lesions with
diverse malignant potential and a range of treatment options. It is the most rapidly growing …

Ductal carcinoma in situ of the breast is a heterogeneous group of lesions with diverse
malignant potential. It is the most rapidly growing subgroup in the breast cancer family; it is …

Ductal carcinoma in situ (DCIS) of the breast is a heterogeneous neoplasm with invasive
potential. Risk factors include age, family history, hormone replacement therapy, genetic …